galactose has been researched along with alpha-synuclein in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chu, V; Conde, JP; Fernandes, JT; Gameiro, A; Outeiro, TF; Tenreiro, S | 1 |
| Allen, KJ; Harkness, TA; Kakish, J; Krol, ES; Lee, JS | 1 |
| Figini, S; Galvani, M; Marinus, J; Mastroberardino, PG; Milanese, C; Molano González, N; Nait Abdellah, S; Payán-Gómez, C; Tresini, M; van Hilten, JJ; van Roon-Mom, WMC | 1 |
3 other study(ies) available for galactose and alpha-synuclein
| Article | Year |
|---|---|
Modulation of alpha-synuclein toxicity in yeast using a novel microfluidic-based gradient generator.
Topics: alpha-Synuclein; Ascorbic Acid; Galactose; Hydrodynamics; Microfluidic Analytical Techniques; Particle Size; Saccharomyces cerevisiae; Surface Properties | 2014 |
Novel Dimer Compounds That Bind α-Synuclein Can Rescue Cell Growth in a Yeast Model Overexpressing α-Synuclein. A Possible Prevention Strategy for Parkinson's Disease.
Topics: alpha-Synuclein; Antiparkinson Agents; Calorimetry; Dimerization; Drug Evaluation, Preclinical; Galactose; Green Fluorescent Proteins; Microscopy, Fluorescence; Parkinson Disease; Protein Binding; Yeasts | 2016 |
Peripheral mitochondrial function correlates with clinical severity in idiopathic Parkinson's disease.
Topics: Adenosine Triphosphate; alpha-Synuclein; Energy Metabolism; Female; Fibroblasts; Galactose; Glucose; Glycolysis; Humans; Machine Learning; Male; Mitochondria; Models, Statistical; Oxidative Phosphorylation; Parkinson Disease; Phosphorylation; Primary Cell Culture; Severity of Illness Index; Skin; Stress, Physiological | 2019 |